相似文献
1
Checking up on checkpoint inhibitors.
Blood. 2017 Jul 13;130(2):107-108. doi: 10.1182/blood-2017-05-783696.
2
Checkpoint kinase inhibitors: a review of the patent literature.
Expert Opin Ther Pat. 2009 Feb;19(2):165-97. doi: 10.1517/13543770802653622.
3
Current inhibitors of checkpoint kinase 2.
Curr Med Chem. 2011;18(28):4368-74. doi: 10.2174/092986711797200390.
4
Drug discovery targeting Chk1 and Chk2 kinases.
Prog Cell Cycle Res. 2003;5:413-21.
5
The radiosensitizing agent 7-hydroxystaurosporine (UCN-01) inhibits the DNA damage checkpoint kinase hChk1.
Cancer Res. 2000 Apr 15;60(8):2108-12.
6
The Hog1 MAP kinase pathway and the Mec1 DNA damage checkpoint pathway independently control the cellular responses to hydrogen peroxide.
DNA Repair (Amst). 2004 Jul 2;3(7):769-76. doi: 10.1016/j.dnarep.2004.03.043.
7
Inhibitors of checkpoint kinases: from discovery to the clinic.
Curr Opin Drug Discov Devel. 2007 Jul;10(4):473-86.
8
An indolocarbazole inhibitor of human checkpoint kinase (Chk1) abrogates cell cycle arrest caused by DNA damage.
Cancer Res. 2000 Feb 1;60(3):566-72.
9
Targeting serine/threonine protein kinase B/Akt and cell-cycle checkpoint kinases for treating cancer.
Curr Top Med Chem. 2002 Sep;2(9):939-71. doi: 10.2174/1568026023393318.
10
A novel role for Chk2 after DNA damage in mitosis?
Cell Cycle. 2010 Jan 1;9(1):25-6.
引用本文的文献
1
Regulation of GVHD and GVL Activity via PD-L1 Interaction With PD-1 and CD80.
Front Immunol. 2018 Dec 21;9:3061. doi: 10.3389/fimmu.2018.03061. eCollection 2018.
本文引用的文献
1
PD-1 blockade for relapsed lymphoma post-allogeneic hematopoietic cell transplant: high response rate but frequent GVHD.
Blood. 2017 Jul 13;130(2):221-228. doi: 10.1182/blood-2017-01-761346. Epub 2017 May 3.
2
PD-L1 interacts with CD80 to regulate graft-versus-leukemia activity of donor CD8+ T cells.
J Clin Invest. 2017 May 1;127(5):1960-1977. doi: 10.1172/JCI91138. Epub 2017 Apr 17.
3
Efficacy and tolerability of nivolumab after allogeneic transplantation for relapsed Hodgkin lymphoma.
Blood. 2017 May 4;129(18):2471-2478. doi: 10.1182/blood-2016-11-749556. Epub 2017 Mar 7.
4
Ipilimumab for Patients with Relapse after Allogeneic Transplantation.
N Engl J Med. 2016 Jul 14;375(2):143-53. doi: 10.1056/NEJMoa1601202.
5
Allogeneic hematopoietic stem cell transplantation in Hodgkin lymphoma: a systematic review and meta-analysis.
Bone Marrow Transplant. 2016 Apr;51(4):521-8. doi: 10.1038/bmt.2015.332. Epub 2016 Jan 4.
6
PD-1 blockade with nivolumab in relapsed or refractory Hodgkin's lymphoma.
N Engl J Med. 2015 Jan 22;372(4):311-9. doi: 10.1056/NEJMoa1411087. Epub 2014 Dec 6.
Zotero 插件